About this trial
Aggressive intravenous hydration has been shown in randomized trials to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), though studied regimens are often impractical. To date, no studies have prospectively assessed short-term (60-90 minute) aggressive hydration regimens that are feasible for outpatients undergoing ERCP and subsequent discharge. Furthermore, little is known with regard to fluid type, volume, and timing with respect to ERCP. In this study, we will aim to assess whether the amount of peri-procedural intravenous fluid administered around the time of ERCP is associated with the risk of PEP (the primary outcome).
Eligibility criteria
Qualifiers
Subject referred for ERCP, regardless of indication;
Subject age 18 years or older;
Subject able to give informed consent to involvement be included.
Disqualifiers
Subject has a standard contraindication to ERCP;
Subject or surrogate unable or unwilling to provide informed consent;
Subject age < 18 years.
Trial design
Treatments tested in this trial
- IV fluids
Treatment groups
Sponsors and collaborators
University of Calgary
Lead sponsor
McGill University
Collaborator
University of Ottawa
Collaborator
Queen's University
Collaborator
Halton Health (Oakville)
Collaborator
Island Health, Victoria, BC
Collaborator